Nanopharmacology focuses on the design, development, and application of nanoscale materials for medical purposes. At the intersection of nanotechnology and pharmacology, this discipline harnesses the unique properties of nanoparticles to revolutionize drug delivery and therapeutic interventions. Nanoparticles, often ranging in size from 1 to 100 nanometers, offer distinct advantages such as increased surface area, enhanced bioavailability, and targeted delivery to specific cells or tissues. In the realm of pharmaceuticals, nanopharmacology holds the promise of overcoming challenges associated with conventional drug delivery systems, including poor solubility and systemic side effects.
By precisely manipulating the physicochemical properties of nanoparticles, researchers aim to optimize drug formulations, improve therapeutic efficacy, and minimize adverse reactions. This field's potential extends beyond drug delivery, as nanopharmacology also explores diagnostic applications and personalized medicine, showcasing its transformative impact on the future of healthcare. As scientists delve deeper into understanding the intricate interactions at the nanoscale, nanopharmacology emerges as a frontier with vast implications for advancing pharmaceutical science and patient care.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia